Ivabradine in the treatment of inappropriate sinus tachycardia in patients after successful radiofrequency catheter ablation of atrioventricular node slow pathway

PACE - Pacing and Clinical Electrophysiology

Volumn 36, Issue 1, 2013, Pages 42-49

  Ptaszynski, Pawel ^a   Kaczmarek, Krzysztof ^a   Ruta, Jan ^a   Klingenheben, Thomas ^b   Wranicz, Jerzy K ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b Cardiology Practice Bonn   (Germany)

Author keywords

atrioventricular nodal reentrant tachycardia; Heart rate; inappropriate sinus tachycardia; ivabradine; radiofrequency catheter ablation

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; IVABRADINE;

ADULT; ARTICLE; BRADYCARDIA; CARDIOPULMONARY EXERCISE TEST; CATHETER ABLATION; CLINICAL ARTICLE; DAILY LIFE ACTIVITY; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSPNEA; EXERCISE TOLERANCE; FEMALE; HEART ATRIOVENTRICULAR NODE; HEART PALPITATION; HEART RATE; HOLTER MONITORING; HUMAN; INAPPROPRIATE SINUS TACHYCARDIA; MALE; POSTOPERATIVE CARE; PRESYNCOPE; REENTRY TACHYCARDIA; SINUS TACHYCARDIA; THORAX PAIN; TREADMILL EXERCISE; TREATMENT DURATION; VISUAL DISORDER;

ADULT; BENZAZEPINES; CATHETER ABLATION; FEMALE; HEART CONDUCTION SYSTEM; HUMANS; MALE; TACHYCARDIA, ATRIOVENTRICULAR NODAL REENTRY; TACHYCARDIA, SINUS; TREATMENT OUTCOME;

EID: 84872193621     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/pace.12018     Document Type: Article

References (25)

1. Blomstrom-Lundqvist C, Scheinman MM, Aliot EM, Alpert JS, Calkins H, Camm AJ, Campbell WB, et al. European Society of Cardiology Committee, NASPE-Heart Rhythm Society: ACC/AHA/ESC guidelines. Task force management of patients with supraventricular arrhythmias: Executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients with Supraventricular Arrhythmias) developed in collaboration with NASPE-Heart Rhythm Society. J Am Coll Cardiol 2003; 42: 1493-1531.
2. Skeberis V, Simonis F, Tsakonas K, Celiker A, Andries E, Brugada P,. Inappropriate sinus tachycardia following radiofrequency ablation of AV nodal tachycardia: Incidence and clinical significance. Pacing Clin Electrophysiol 1994; 17: 924-927.
3. Femenia F, Baranchuk A, Morillo CA,. Inappropriate sinus tachycardia: current therapeutic options. Cardiol Rev 2012; 20: 8-14.
4. Ehlert FA, Goldberger JJ, Brooks R, Miller S, Kadish AH,. Persistent inappropriate sinus tachycardia after radiofrequency current catheter modification of the atrioventricular node. Am J Cardiol 1992; 69: 1092-1095.
5. Geller C, Goette A, Carlson MD, Esperer HD, Hartung WM, Auricchio A, Klein HU,. An increase in sinus rate following radiofrequency energy application in the posteroseptal space. Pacing Clin Electrophysiol 1998; 21: 303-307.
6. Pappone C, Stabile G, Oreto G, De Simone A, Rillo M, Mazzone P, Cappato R, et al. Inappropriate sinus tachycardia after radiofrequency ablation of para-Hisian accessory pathways. J Cardiovasc Electrophysiol 1997; 8: 1357-1365.
7. Uchida F, Kasai A, Omichi C, Fujii E, Teramura S, Yasuda M, Nakano T,. Effect of radiofrequency catheter ablation on parasympathetic denervation: A comparison of three different ablation sites. Pacing Clin Electrophysiol 1998; 21: 2517-2521.
8. Moreira JM, Curimbaba J, Filho HC, Pimenta J,. Persistent inappropriate sinus tachycardia after radiofrequency ablation of left lateral accessory pathway. J Cardiovasc Electrophysiol 2006; 17: 678-681.
9. Kowallik P, Escher S, Peters W, Braun C, Meesmann M,. Preserved autonomic modulation of the sinus and atrioventricular nodes following posteroseptal ablation for treatment of atrioventricular nodal reentrant tachycardia. J Cardiovasc Electrophysiol 1998; 9: 567-573.
10. Guo H, Wang P, Xing Y, Peng F, Jiang J, Yang B, You B, et al. Delayed injury of autonomic nerve induced by radiofrequency catheter ablation. J Electrocardiol 2007; 40: 355.e1-4.
11. Kirchhof P, Auricchio A, Bax J, Crijns H, Camm J, Diener HC, Goette A, et al. Outcome parameters for trials in atrial fibrillation: Executive summary. Recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork (AFNET) and the European Heart Rhythm Association (EHRA). Eur Heart J 2007; 28: 2803-2817.
12. Friedman PL, Stevenson WG, Kocovic DZ,. Autonomic dysfunction after catheter ablation. J Cardiovasc Electrophysiol 1996; 7: 450-459.
13. Duru F, Bauersfeld U, Candinas R,. Autonomic effects of radiofrequency catheter ablation. Europace 2000; 2: 181-185.
14. Fox K, Ford I, Steg PG, Tendera M, Ferrari R, BEAUTIFUL Investigators. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): A randomized, double-blind, placebo-controlled trial. Lancet 2008; 372: 807-16.
15. Swedberg K, Komajda M, Böhm M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, et al. Ivabradine and outcomes in chronic heart failure (SHIFT): A randomized placebo-controlled study. Lancet 2010; 376: 875-885.
16. Retegui G, Quintero M, Ruiz-Borrell M, Revello A,. Ivabradine as a treatment option for inappropriate sinus tachycardia. Rev Esp Cardiol 2009; 62: 577-579.
17. Rakovec P,. Treatment of inappropriate sinus tachycardia with ivabradine. Wien Klin Wochenschr 2009; 121: 716-718.
18. Calò L, Rebecchi M, Sette A, Martino A, de Ruvo E, Sciarra L, De Luca L, et al. Efficacy of ivabradine administration in patients affected by inappropriate sinus tachycardia. Heart Rhythm 2010; 7: 1318-1323.
19. Kaplinsky E, Comes FP, Urondo LS, Ayma FP,. Efficacy of ivabradine in four patients with inappropriate sinus tachycardia: A three month-long experience based on electrocardiographic, Holter monitoring, exercise tolerance and quality of life assessment. Cardiol J 2010; 17: 166-171.
20. Zellerhoff S, Hinterseer M, Krull BF, Schulze-Bahr E, Fabritz L, Breithardt G, Kirchhof P, et al. Ivabradine in patients with inappropriate sinus tachycardia. Naunyn-Schmied Arch Pharmacol 2010; 382: 483-486.
21. Winum P-F, Cayala G, Rubini M, Beck L, Messner-Pellenc P,. A case of cardiomyopathy induced by inappropriate sinus tachycardia and cured by ivabradine. Pacing Clin Electrophysiol 2009; 32: 942-944.
22. Capulzini L, Sarkozy A, Semeraro O, Paparella G, Chierchia GB, DE Asmundis C, Roos M, et al. Ivabradine to treat inappropriate sinus tachycardia after the fast pathway ablation in a patient with severe pectus excavatum. Pacing Clin Electrophysiol 2009; 33: e1-4.
23. DiFrancesco D, Camm JA,. Heart rate lowering by specific and selective If current inhibition with ivabradine: A new therapeutic perspective in cardiovascular disease. Drugs 2004; 64: 1757-1765.
24. Tardif JC, Ford I, Tendera M, Bourassa MG, Fox K,; INITIATIVE Investigators. Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina. Eur Heart J 2005; 26: 2529-2536.
25. Tardif JC, Ponikowski P, Kahan T,; ASSOCIATE Study Investigators. Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: A 4-month, randomized, placebo-controlled trial. Eur Heart J 2009; 30: 540-548.